GeoVax Labs (GOVX)
(Real Time Quote from BATS)
$0.66 USD
-0.07 (-9.50%)
Updated Aug 6, 2025 03:53 PM ET
After-Market: $0.66 0.00 (0.00%) 4:16 PM ET
2-Buy of 5 2
F Value A Growth B Momentum C VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
GOVX 0.66 -0.07(-9.50%)
Will GOVX be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for GOVX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for GOVX
Should You Buy GeoVax Labs Inc. (GOVX) After Golden Cross?
Zacks Investment Ideas feature highlights: Virax Biolabs Group, GeoVax Labs, Applied DNA Sciences and Emergent BioSolutions
GOVX: What are Zacks experts saying now?
Zacks Private Portfolio Services
WHO Declares Monkeypox Public Emergency: 5 Mpox Stocks to Watch
Other News for GOVX
GOVX: Geovax Labs Maintains "Buy" Rating and $9 Price Target | GOVX Stock News
Geovax Labs Inc (GOVX) Q2 2025 Earnings Call Highlights: Revenue Surge and Strategic ...
Q2 2025 GeoVax Labs Inc Earnings Call Transcript
Here are the major earnings after the close Monday
GeoVax Labs, Inc. (GOVX) Q2 2025 Earnings Call Transcript